Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;75(11):1704–1707. doi: 10.1038/bjc.1997.290

Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa.

F Sitas 1, W R Bezwoda 1, V Levin 1, P Ruff 1, M C Kew 1, M J Hale 1, H Carrara 1, V Beral 1, G Fleming 1, R Odes 1, A Weaving 1
PMCID: PMC2223539  PMID: 9184191

Abstract

A case-control study of 913 black cancer patients (aged 15-50 years) was undertaken to measure the association between human immunodeficiency (HIV) infection and cancers believed to have an infective aetiology. Controls were patients with cancers believed not to be infective in origin. The prevalence of HIV in the controls of 7.3% (24 of 325) was similar to the background HIV seropositivity in this population. Odds ratios (ORs) and 95% confidence intervals (CI) adjusted for age, year of diagnosis, marital status and sex were calculated. There was a strong association between HIV infection and Kaposi's sarcoma (KS), with 27 of 33 cases being HIV seropositive, OR = 61.8 (95% CI 19.7-194.2) and an elevated association with non-Hodgkin's lymphoma (NHL), with 27 of 40 cases being HIV seropositive [OR = 4.8 (95% CI 1.5-14.8)]. The elevated odds ratio for KS associated with HIV infection accords with the observed increases in the incidence of KS in several sub-Saharan African countries where the prevalence of HIV is high. The odds ratio for NHL associated with HIV infection was lower than that reported in developed countries, and the reason for this is not clear. No other cancers, including cervical and liver cancers, showed significantly elevated odds ratios associated with HIV infection.

Full text

PDF
1704

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barra S., Barón A. E., Franceschi S., Talamini R., La Vecchia C. Cancer and non-cancer controls in studies on the effect of tobacco and alcohol consumption. Int J Epidemiol. 1991 Dec;20(4):845–851. doi: 10.1093/ije/20.4.845. [DOI] [PubMed] [Google Scholar]
  2. Bassett M. T., Chokunonga E., Mauchaza B., Levy L., Ferlay J., Parkin D. M. Cancer in the African population of Harare, Zimbabwe, 1990-1992. Int J Cancer. 1995 Sep 27;63(1):29–36. doi: 10.1002/ijc.2910630107. [DOI] [PubMed] [Google Scholar]
  3. Beral V., Peterman T., Berkelman R., Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet. 1991 Apr 6;337(8745):805–809. doi: 10.1016/0140-6736(91)92513-2. [DOI] [PubMed] [Google Scholar]
  4. Beral V. The epidemiology of cancer in AIDS patients. AIDS. 1991;5 (Suppl 2):S99–103. doi: 10.1097/00002030-199101001-00014. [DOI] [PubMed] [Google Scholar]
  5. Bourdeaux L., Renard F., Gigase P. L., Mukolo-Ndjolo, Maldague P., De Muynck A. L'incidence des cancers à l'hôpital de Katana, Kivu, Est-Zaïre, de 1983 à 1986. Ann Soc Belg Med Trop. 1988 Jun;68(2):141–156. [PubMed] [Google Scholar]
  6. Buehler J. W., Hanson D. L., Chu S. Y. The reporting of HIV/AIDS deaths in women. Am J Public Health. 1992 Nov;82(11):1500–1505. doi: 10.2105/ajph.82.11.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994 Dec 16;266(5192):1865–1869. doi: 10.1126/science.7997879. [DOI] [PubMed] [Google Scholar]
  8. Dillner J., Knekt P., Schiller J. T., Hakulinen T. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. BMJ. 1995 Nov 18;311(7016):1346–1346. doi: 10.1136/bmj.311.7016.1346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kinlen L. Immunosuppressive therapy and acquired immunological disorders. Cancer Res. 1992 Oct 1;52(19 Suppl):5474s–5476s. [PubMed] [Google Scholar]
  10. Lehtinen T., Lumio J., Dillner J., Hakama M., Knekt P., Lehtinen M., Teppo L., Leinikki P. Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective study. Cancer Causes Control. 1993 May;4(3):187–193. doi: 10.1007/BF00051312. [DOI] [PubMed] [Google Scholar]
  11. Newton R., Grulich A., Beral V., Sindikubwabo B., Ngilimana P. J., Nganyira A., Parkin D. M. Cancer and HIV infection in Rwanda. Lancet. 1995 May 27;345(8961):1378–1379. doi: 10.1016/s0140-6736(95)92583-x. [DOI] [PubMed] [Google Scholar]
  12. Parkin D. M., Vizcaino A. P., Skinner M. E., Ndhlovu A. Cancer patterns and risk factors in the African population of southwestern Zimbabwe, 1963-1977. Cancer Epidemiol Biomarkers Prev. 1994 Oct-Nov;3(7):537–547. [PubMed] [Google Scholar]
  13. Patil P., Elem B., Zumla A. Pattern of adult malignancies in Zambia (1980-1989) in light of the human immunodeficiency virus type 1 epidemic. J Trop Med Hyg. 1995 Aug;98(4):281–284. [PubMed] [Google Scholar]
  14. Rabkin C. S., Biggar R. J., Horm J. W. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer. 1991 Mar 12;47(5):692–696. doi: 10.1002/ijc.2910470511. [DOI] [PubMed] [Google Scholar]
  15. Rabkin C. S., Blattner W. A. HIV infection and cancers other than non-Hodgkin lymphoma and Kaposi's sarcoma. Cancer Surv. 1991;10:151–160. [PubMed] [Google Scholar]
  16. Wabinga H. R., Parkin D. M., Wabwire-Mangen F., Mugerwa J. W. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer. 1993 Apr 22;54(1):26–36. doi: 10.1002/ijc.2910540106. [DOI] [PubMed] [Google Scholar]
  17. ter Meulen J., Eberhardt H. C., Luande J., Mgaya H. N., Chang-Claude J., Mtiro H., Mhina M., Kashaija P., Ockert S., Yu X. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa. Int J Cancer. 1992 Jun 19;51(4):515–521. doi: 10.1002/ijc.2910510403. [DOI] [PubMed] [Google Scholar]
  18. zur Hausen H. Viruses in human cancers. Science. 1991 Nov 22;254(5035):1167–1173. doi: 10.1126/science.1659743. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES